Precision Medicine: Patent and Regulatory Frameworks in Canada
October 7, 2014
In the October/November issue of Biotechnology Focus, Carmela De Luca and Amy Dam write about “precision medicine” and provide a review of some Canadian-specific scenarios under the current legal regimes that may influence development of its technologies.
Content shared on Bereskin & Parr’s website is for information purposes only. It should not be taken as legal or professional advice. To obtain such advice, please contact a Bereskin & Parr LLP professional. We will be pleased to help you.